Q-Line Biotec’s SME IPO has not even opened for subscription yet — it opens on May 21 — but the grey market is already pricing in a 32.36% listing gain, with the GMP climbing to ₹111 on Wednesday morning, placing the estimated listing price at ₹454 against the upper price band of ₹343 per share.
Issue details
The biotech company’s IPO will be listed on the NSE SME platform. The total issue size is ₹214.48 crore with a price band of ₹326 to ₹343 per share and a minimum lot size of 400 shares. Subscription opens May 21 and closes May 25, with basis of allotment on May 26 and the tentative listing date fixed as May 29, 2026.
GMP trend — moving fast in four days
Grey market activity has accelerated sharply in a short window. The GMP stood at zero on May 17, jumped to ₹69 on May 18, climbed further to ₹110 on May 19, and reached ₹111 on Wednesday — a move from zero to a 32% implied premium in just three sessions. Based on the current GMP and lot size of 400 shares, the estimated grey market profit per lot stands at ₹44,400. The retail subject to sauda figure is quoted at ₹33,700. Investor sentiment based on the last three GMP sessions is classified as bullish at 80%.
GMP data is unofficial and speculative in nature and does not constitute a recommendation to apply. This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making any investment decisions.